SYRE
Price
$32.20
Change
+$3.80 (+13.38%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
2.22B
84 days until earnings call
Intraday BUY SELL Signals
TERN
Price
$27.48
Change
+$1.69 (+6.55%)
Updated
Dec 3, 04:59 PM (EDT)
Capitalization
2.48B
117 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

SYRE vs TERN

Header iconSYRE vs TERN Comparison
Open Charts SYRE vs TERNBanner chart's image
Spyre Therapeutics
Price$32.20
Change+$3.80 (+13.38%)
Volume$57.92K
Capitalization2.22B
Terns Pharmaceuticals
Price$27.48
Change+$1.69 (+6.55%)
Volume$41.75K
Capitalization2.48B
SYRE vs TERN Comparison Chart in %
SYRE
Daily Signal:
Gain/Loss:
TERN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
SYRE vs. TERN commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SYRE is a Hold and TERN is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 04, 2025
Stock price -- (SYRE: $28.40 vs. TERN: $25.79)
Brand notoriety: SYRE and TERN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SYRE: 23% vs. TERN: 49%
Market capitalization -- SYRE: $2.22B vs. TERN: $2.48B
SYRE [@Biotechnology] is valued at $2.22B. TERN’s [@Biotechnology] market capitalization is $2.48B. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SYRE’s FA Score shows that 0 FA rating(s) are green whileTERN’s FA Score has 0 green FA rating(s).

  • SYRE’s FA Score: 0 green, 5 red.
  • TERN’s FA Score: 0 green, 5 red.
According to our system of comparison, TERN is a better buy in the long-term than SYRE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SYRE’s TA Score shows that 4 TA indicator(s) are bullish while TERN’s TA Score has 4 bullish TA indicator(s).

  • SYRE’s TA Score: 4 bullish, 4 bearish.
  • TERN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both SYRE and TERN are a good buy in the short-term.

Price Growth

SYRE (@Biotechnology) experienced а -2.74% price change this week, while TERN (@Biotechnology) price change was -12.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +1.23%, and the average quarterly price growth was +54.93%.

Reported Earning Dates

SYRE is expected to report earnings on Feb 26, 2026.

TERN is expected to report earnings on Mar 31, 2026.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TERN($2.48B) has a higher market cap than SYRE($2.22B). TERN YTD gains are higher at: 365.523 vs. SYRE (21.993). TERN has higher annual earnings (EBITDA): -105M vs. SYRE (-222.15M). SYRE has more cash in the bank: 527M vs. TERN (315M). SYRE has less debt than TERN: SYRE (0) vs TERN (1.13M). SYRE (0) and TERN (0) have equivalent revenues.
SYRETERNSYRE / TERN
Capitalization2.22B2.48B90%
EBITDA-222.15M-105M212%
Gain YTD21.993365.5236%
P/E Ratio1.72N/A-
Revenue00-
Total Cash527M315M167%
Total Debt01.13M-
FUNDAMENTALS RATINGS
SYRE: Fundamental Ratings
SYRE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
74
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SYRETERN
RSI
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
77%
Stochastic
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 6 days ago
87%
Momentum
ODDS (%)
Bullish Trend 6 days ago
87%
Bullish Trend 6 days ago
84%
MACD
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 6 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 6 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 6 days ago
89%
Advances
ODDS (%)
Bullish Trend 6 days ago
85%
Bullish Trend 9 days ago
82%
Declines
ODDS (%)
Bearish Trend 28 days ago
90%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 6 days ago
80%
Aroon
ODDS (%)
Bullish Trend 6 days ago
82%
Bullish Trend 6 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
SYRE
Daily Signal:
Gain/Loss:
TERN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AEDYX37.56N/A
N/A
Invesco International Value Y
PMJPX11.84N/A
N/A
PIMCO RAE US Small I-2
HDGSX39.05N/A
N/A
Hartford Dividend and Growth R4
BRULX17.19N/A
N/A
MFS Blended Research Value Equity R3
DLCIX25.50N/A
N/A
Dana Large Cap Equity Institutional

SYRE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYRE has been loosely correlated with APGE. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if SYRE jumps, then APGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYRE
1D Price
Change %
SYRE100%
-0.91%
APGE - SYRE
58%
Loosely correlated
+0.20%
CGON - SYRE
58%
Loosely correlated
-4.35%
RGNX - SYRE
57%
Loosely correlated
-3.10%
IDYA - SYRE
57%
Loosely correlated
-1.75%
ORKA - SYRE
56%
Loosely correlated
+0.56%
More

TERN and

Correlation & Price change

A.I.dvisor indicates that over the last year, TERN has been loosely correlated with ELVN. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if TERN jumps, then ELVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TERN
1D Price
Change %
TERN100%
-6.32%
ELVN - TERN
42%
Loosely correlated
+3.68%
MLTX - TERN
40%
Loosely correlated
-5.36%
STOK - TERN
40%
Loosely correlated
-1.00%
SYRE - TERN
40%
Loosely correlated
-0.91%
IDYA - TERN
36%
Loosely correlated
-1.75%
More